Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity.
Al-Dulaimi S, Thomas R, Matta S et al. · Biogerontology · PMID 40908429
A published correction is linked in the original PubMed record.
Study summary
Main finding
The researchers observed telomere extension with telomerase-related changes in normal cultured cells. Breast-cancer cell lines also showed extension, associated with alternative lengthening of telomeres (ALT).
Normal human cell cultures & breast-cancer cell lines
How the study was set up
Epitalon was tested in normal epithelial and fibroblast cultures and in two breast-cancer cell lines. Researchers extracted DNA, RNA, and proteins for laboratory analysis.
What the researchers measured
Telomere length, hTERT gene expression, telomerase activity, and alternative lengthening of telomeres (ALT), using qPCR and fluorescence-based analysis. ALT is a pathway that can maintain telomeres without telomerase.
How to read this evidence
Researchers studied cells, isolated tissue, or animals. These experiments can help explain a mechanism, but do not establish benefits or safety in people. Human cells grown in a laboratory also belong in this category.
Results in context
Normal and cancer cells did not show the same dominant pathway: telomerase-related changes were reported in normal cells, while ALT activity was prominent in cancer cells. Telomere extension across these models should not be presented as a uniform beneficial or safe outcome.
What this does not establish
These are cell-line experiments, not a human longevity trial. Results in cancer cells require separate interpretation and do not establish safety or reversal of aging.
Publication & source
Why this paper is included
The compound is a named subject of the publication title.
Publication indexing
Journal Article · Research Support, Non-U.S. Gov't